Mirabegron (m12)(1365244-66-1)
- Name: Mirabegron (m12)
- Synonyms:Mirabegron (m12);1365244-66-1;YM-538858;Keto mirabegron N-carbamoylglucuronide;UNII-9B7762GTP4;9B7762GTP4;2-Oxo-mirabegron N-Carbamoylglucuronide;(2S,3S,4S,5R,6S)-6-[2-[4-[[2-(2-amino-1,3-thiazol-4-yl)acetyl]amino]phenyl]ethyl-phenacylcarbamoyl]oxy-3,4,5-trihydroxyoxane-2-carboxylic acid;beta-D-Glucopyranuronic acid, 1-(N-(2-(4-((2-(2-amino-4-thiazolyl)acetyl)amino)phenyl)ethyl)-N-(2-oxo-2-phenylethyl)carbamate);CHEMBL3542358;Q27272302;.BETA.-D-GLUCOPYRANURONIC ACID, 1-(N-(2-(4-((2-(2-AMINO-4-THIAZOLYL)ACETYL)AMINO)PHENYL)ETHYL)-N-(2-OXO-2-PHENYLETHYL)CARBAMATE);2-(2-Aminothiazole-4-yl)-N-[4-[2-[phenacyl(beta-D-glucurono pyranosyloxycarbonyl)amino]ethyl]phenyl]acetamide
- Molecular Formula:C28H30N4O10S
- Molecular Weight:614.6
- CAS Registry Number:1365244-66-1
- EINECS:
- Melting Point:
- Water Solubility:
CAS No.1365244-66-1 Mirabegron M12 (YM-538858)
Assay:95%+ or 98%+ Appearance:solid Package:10mg/25mg/50mg/100mg/1000mg/5000mg Storage:short-term storage normal temperature. long-term storage 2-8 鈩?nbsp;Application:for drug impurities, for drug standards,for drug research and development
Min. Order:0
Supplier:Hubei Moxin Biotechnology Co., Ltd [
China (Mainland)]
Other Product
- 16031-76-8/N-[(Z)-(3'-phenylspiro[3H-indene-2,2'-oxirane]-1-ylidene)amino]aniline
- 916420-56-9/3-Methyl-5-(trifluoromethoxy)phenylacetonitrile
- 370094-12-5/Diltiazem Sulfoxide
- 297176-96-6/Beheneth-3
- 69536-25-0/9-Phenyl-8-oxa-10,12-diazatricyclo[7.3.1.02,7]trideca-2(7),3,5,11-tetraen-5-ol;hydrochloride
- 2133460-42-9/Unii-3PF93NM6VT
- 103554-60-5/1-Butanesulfonamide, monomethanesulfonate
- 1187930-16-0/5-Bromo-6-pyrrolidin-1-YL-nicotinic acid
- 1897428-40-8/2,2,4-Trimethylpyrrolidine hydrochloride
- 1390654-80-4/1390654-80-4
- 1306738-68-0/Ethyl 7-methyl-2-[(4-methylbenzyl)thio][1,2,4]triazolo[1,5-a]pyrimidine-6-carboxylate
- 869941-78-6/4-allyl-5-ethyl-4H-1,2,4-triazole-3-thiol
- 218594-73-1/(3R)-4-benzyl-3-methoxymethylmorpholine
- 952182-81-9/N'-Hydroxy-2-(3-methylpiperidin-1-yl)acetimidamide
- 31844-14-1/5,12-Dipropyl-5,12-diazapentacyclo[7.5.2.02,8.03,7.010,14]hexadec-15-ene-4,6,11,13-tetrone
- 1131622-31-5/1-(3-Carboxyphenyl)-3-n-butyl piperazine
- 1565482-62-3/Ornidazole metabolite M2
- 883543-40-6/1-(4-Methyl-piperidin-1-ylmethyl)-propylamine
- 5462-12-4/4,4'-Methylenebis(3-hydroxynaphthalene-2-carboxylic acid)--4-[(2-methoxynaphthalen-1-yl)methyl]-N,N,3-trimethylaniline (1/1)
- 1365244-66-1/Mirabegron (m12)
- 149773-86-4/2',4'-Difluoroacetophenone oxime
- 17001-85-3/Sulfuric acid--5-(3-methylbutyl)-N~2~-(3-phenylpropyl)pyrimidine-2,4,6-triamine (1/1)
- 91393-18-9/3-(4-Methyl-1-oxophthalazin-2(1H)-yl)propanoic acid
- 211315-05-8/1-(4-Tert-butylphenyl)cyclopropanecarboxylic acid
- 1221791-74-7/8-Cyclohexyl-1-thia-4,8-diazaspiro[4.5]decane hydrochloride
- 10310-46-0/Diethyl 2-aminopentanedioate
- 1809403-05-1/Canagliflozin hemihydrate
- 1119450-46-2/2-bromo-N-[2-(4-chlorophenyl)ethyl]propanamide
- 50866-24-5/1-[3-(Aminomethyl)phenyl]-6,6-dimethyl-1,3,5-triazine-2,4-diamine;ethanesulfonic acid
- 914287-54-0/3-(4-Chlorophenyl)-5-(methoxymethyl)-1,2-oxazole-4-carbaldehyde